SG Americas Securities, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,877,000
-12.0%
10,909
-35.8%
0.01%
-10.0%
Q2 2021$2,132,000
-3.5%
16,986
+4.2%
0.01%
-16.7%
Q1 2021$2,210,000
+1525.0%
16,299
+1431.9%
0.01%
+1100.0%
Q4 2020$136,000
-83.5%
1,064
-85.4%
0.00%
-80.0%
Q3 2020$822,000
+319.4%
7,308
+254.4%
0.01%
+150.0%
Q2 2020$196,000
-95.8%
2,062
-96.1%
0.00%
-95.5%
Q1 2020$4,708,000
+1226.2%
52,385
+682.0%
0.04%
+1366.7%
Q4 2019$355,000
+219.8%
6,699
+139.2%
0.00%
+200.0%
Q3 2019$111,000
-75.4%
2,801
-74.6%
0.00%
-66.7%
Q2 2019$452,000
-37.0%
11,015
-28.5%
0.00%
-57.1%
Q1 2019$717,000
-58.0%
15,398
-60.7%
0.01%
-53.3%
Q4 2018$1,707,000
+1607.0%
39,188
+1794.1%
0.02%
+1400.0%
Q2 2018$100,000
-8.3%
2,069
-25.6%
0.00%0.0%
Q1 2018$109,000
-76.1%
2,782
-77.3%
0.00%
-75.0%
Q3 2017$457,000
+221.8%
12,239
+161.9%
0.00%
+300.0%
Q2 2017$142,000
+10.1%
4,673
-3.9%
0.00%0.0%
Q1 2017$129,000
-69.1%
4,864
-70.3%
0.00%
-75.0%
Q4 2016$417,000
+30.3%
16,350
+84.8%
0.00%
+33.3%
Q3 2016$320,000
+114.8%
8,849
+56.8%
0.00%
+200.0%
Q1 2016$149,000
+4.2%
5,642
+25.0%
0.00%0.0%
Q2 2015$143,000
-9.5%
4,513
+11.3%
0.00%0.0%
Q4 2014$158,000
-50.3%
4,054
-56.1%
0.00%0.0%
Q1 2014$318,0009,2280.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders